Back to search
Prediabetes / Type 2 Diabetes
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Prediabetes / Type 2 Diabetes trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Prediabetes / Type 2 Diabetes trials you may qualify forGestational diabetes (GDM) is an important contributor to the increasing prevalence of type 2 diabetes (T2DM). Women with glucose intolerance in early postpartu…
Prediabetes affects over one-third of adults in the United States, placing them at a higher risk for developing type 2 diabetes and heart disease, which can lea…
Fasting hyperglycemia contributes disproportionately to nonenzymatic glycosylation and the microvascular complications of type 2 diabetes. However, little is kn…
This study is to investigate how adipocyte (fat cell) function and fat distribution differ between individuals with normal-weight type 2 diabetes (NWD), those w…
Individuals with lactase non-persistence (LNP; determined by a functional variant in the LCT gene \[rs4988235, GG genotype\]) are susceptible to lactose intoler…
TRANSFORM is a prospective, randomized, open blinded endpoint (PROBE), event-driven, pragmatic trial in patients who are at increased risk for atherosclerotic c…
The purpose of this clinical trial is to find out whether one type of fish oil works better than another at improving metabolic health in people who are at high…
The study team's central hypothesis is that the Parkland Diabetes Detection Program (PDDP) screening invitations targeted by race/ethnicity with culturally conc…